2011 Grants Awarded
“Pseudomyxoma Peritonei: Prognostic Analysis of Micro-RNA and Other Biological Factors Using Tissue Microarray”
Marcello Deraco, MD, Director, Peritoneal Surface Malignancy Management Program, Fondazione IRCCS Instituto Nazionale Tumor (National Cancer Institute), Milano, Italy
$50,000/2 year
“Sequencing the Cancer Genome of Mucinous Adenocarcinoma of the Appendix”
Andrew Lowy,MD, Chief, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, CA, USA
$50,000/2 year
“Preclinical Targeting of the Goblet Cell Differentiation Pathway in Pseudomyxoma Peritonei”
Andrew Renehan, PhD, FRCS, Senior Lecturer in Cancer Studies and Surgery, School of Cancer and Enabling Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
$50,000/2 year
2010 Grants Awarded
“Treating PMP Using Small Molecule Inhibitors of Gel-forming Mucin Productions”
Zongsheng Guo, Ph.D., Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USA
$50,000/2 year
“MicroRNA Profiling of Clinically Different Pseudomyxoma Peritonei Phenotypes”
Brendan Moran, MD, FRCS; Alex Mirnezami, PhD, FRCS, National Pseudomyxoma Peritonei Center-Basingstoke and North Hampshire Hospital NHS Foundation Trust, Basingstoke, UK --and-- The Cancer Research UK Center, Southampton General Hospital, Southampton, UK
$50,000/2 year
“Translational Biology of Pseduomyxoma Peritonei”
Aaron A. Mansfield, MD; Robert Miller, MD, MS; Julian Molina, MD, PhD; Fernando Quevado, MD, Department of Radiation Oncology and Division of Medical Oncology, Mayo Clinic, Rochester, MN
$50,000/2 year
2009 Grants Awarded
“Identification of molecular targets in pseudomyxoma peritonei via clonal analyses of metastases”
Herbert Zeh, MD, PhD;
Co-Director, UPCI GI Oncology Program, Assistant Professor of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USA
$50,000/2 year
Awarded in honor of Dutch Culbertson
“Establishing Methods for Evaluating Anti-tumor Therapies for Treatment of Pseudomyxoma Peritonei Using Gene Profiles and Immortalized Cells”
Andrew Renehan, MD, PhD;
Senior Lecturer in Cancer Studies and Surgery, Department of Surgery and Peritoneal Tumor Service, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK
$50,000/2 year
Awarded in Honor of Jerry Lewandowski
"Development of Animal Models for the Study of Pseudomyxoma and Evaluation of the Role of Anti-Angiogenesis in the Control of this Tumor"
Marc Pocard, MD, PhD; Professor of Surgery, Director of Research, National Institute of Health and Medical Research, Hopital Lariboisiere & Director, Angiogenesis and Translational Research Unit, Paris, France
$50,000/2 year
Awarded in honor of Mel R. Kurtz